The global Proteomics Market size was USD 21.12 billion in 2019 and is Projected to grow to USD 49.97 billion by 2027, with a CAGR of 12.2% during the period 2020 to 2027.
Allied Market Research published a report, titled, “Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027.” The report offers a comprehensive analysis of top winning strategies, recent developments, market dynamics, key segments, and market players.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1677
Rise in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components drive the growth of the global proteomics market. However, lack of skilled professionals and high costs related to proteomics components restrain the growth. On the other hand, biomarker identification and advancements in mass spectrometry-based proteomics are expected to usher a plethora of opportunities in the near future.
The key Players of the Proteomics Market:-
- Agilent Technologies Inc.
- Danaher Corporation
- LI-COR, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- HORIBA, Ltd.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- General Electric (GE)
- Waters Corporation
The reagents segment to dominate throughout the forecast period-
Based on type, the reagents segment has accounted for more than three-fourths of the global proteomics market share in 2019 and will continue to lead by 2027. This is due to increased adoption of proteomics in diagnostic and medical industry. However, the instruments segment is expected to grow at the highest CAGR of 14.1% from 2020 to 2027, owing to unprecedented increase in R&D activities for the development of novel instruments that can be used for studying structure and functional roles of encoded proteins.
The drug discovery segment to lead the trial by 2027-
Based on application, the drug discovery segment contributed around three-fifths of the global proteomics market share in 2019, and will maintain its dominance during the forecast period. Introduction of safer, effective, and cost-effective drugs is expected to be the ultimate outcome of improvement of proteomics technology, which drives the growth of the segment. On the other hand, the disease diagnosis segment is expected to manifest the fastest CAGR of 12.6% during the forecast period.
North America to rule the roost throughout the forecast period-
Based on region, the market across North America accounted for nearly two-fifths of the global proteomics market share in 2019 and will maintain its leadership status by 2027. Proteomics research received a major boost in North America, due to the funding support by government organization. Therefore, increase in investments for R&D drives the market growth in this province. On the other hand, the Asia-Pacific region is expected to witness the highest growth rate, with a CAGR of 15.6 % from 2020 to 2027, owing to rise in demand for drug discovery and advances in the biotechnology sector.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1677
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2027?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
Other Top Trending Reports are:
- Cough Syrup Market Size, Share, Trends Analysis By 2030
- Idiopathic Pulmonary Fibrosis Market Size, Share, Trends Analysis By 2030
- Rheumatoid Arthritis Drugs Market Size, Share, Trends Analysis By 2030
About US
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.